AusPAR: Onbevzi

Australian Public Assessment Report

AusPAR

AusPAR: ONBEVZI [PDF, 574.47 KB]

AusPAR: ONBEVZI [Word, 618.73 KB]

Attachment Product information for ONBEVZI [PDF, 574.17 KB]

Attachment Product information for ONBEVZI [Word, 307.64 KB]

Device/Product Name

Onbevzi

Active ingredients

Bevacizumab

AusPAR Date

15 April 2024

Published

22 May 2024

Submission Number

PM-2021-04826-1-4

Submission Type

New biosimilar medicine

Decision

Approved